Recordkeeping fees per participant
not reported
Not reported on this filing.
Employers › Syros Pharmaceuticals
Syros Pharmaceuticals 401(k)
- Manufacturing
- Mesa, AZ
- EIN 45-3772460
- 1 plan with Schedule H financials
- Plan year 2024
- Syros Pharmaceuticals, Inc.
Administrative expenses excluding investment management, per participant · Syros Pharmaceuticals, Inc. 401(k) Plan · plan year 2024
$852.18
Higher than 100% of the 14,713 plans $1 to 10M that report it.
Source
= $51,983 / 61
derived, admin_expenses (2i(12)) minus invst_mgmt_fees (2i(5)), floored at 0; filing 20250723095416NAL0001783747002, received 2025-07-23
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20250723095416NAL0001783747002, received 2025-07-23
Percentiles compare this plan with the Schedule H plans $1 to 10M in assets of the same plan year, excluding final filings; shown only where at least 50 comparable plans report the figure. Plan year 2024-01-01 to 2024-12-31, filing received 2025-07-23.
Cost and contributions
Administrative expenses per participant
$852.18
Higher than 100% of the 15,210 plans $1 to 10M that report it.
Source
= $51,983 / 61
Schedule H, line 2i(12) total administrative expenses; TOT_ADMIN_EXPENSES_AMT pos 109; filing 20250723095416NAL0001783747002, received 2025-07-23
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20250723095416NAL0001783747002, received 2025-07-23
Administrative expenses as a share of assets
0.847%
Higher than 78% of the 15,243 plans $1 to 10M that report it.
Source
= $51,983 / $6,138,560
Schedule H, line 2i(12) total administrative expenses; TOT_ADMIN_EXPENSES_AMT pos 109; filing 20250723095416NAL0001783747002, received 2025-07-23
assets_eoy: Schedule H, Part I line 1f col (b); TOT_ASSETS_EOY_AMT pos 61; filing 20250723095416NAL0001783747002, received 2025-07-23
Employer contributions per participant
$9,931
Higher than 100% of the 13,342 plans $1 to 10M that report it.
Source
= $605,771 / 61
Schedule H, Part II line 2a(1)(A); EMPLR_CONTRIB_INCOME_AMT pos 68; filing 20250723095416NAL0001783747002, received 2025-07-23
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20250723095416NAL0001783747002, received 2025-07-23
Employer share of total contributions
23.7%
Higher than 34% of the 13,370 plans $1 to 10M that report it.
Source
= $605,771 / $2,553,479
Schedule H, Part II line 2a(1)(A); EMPLR_CONTRIB_INCOME_AMT pos 68; filing 20250723095416NAL0001783747002, received 2025-07-23
total_contrib: Schedule H, line 2a(3); TOT_CONTRIB_AMT pos 72; filing 20250723095416NAL0001783747002, received 2025-07-23
Plan terms, as stated in Syros Pharmaceuticals, Inc.'s SEC filings
Plan terms are described in Syros Pharmaceuticals, Inc.'s SEC filings: Form 10-K filed 2024-03-27. No term could be quoted from them with the required precision.
Plan features
2E profit-sharing · 2J 401(k) feature · 2K 401(m) arrangement · 2T default investment (QDIA) · 2S pre-approved plan document · 2F ERISA 404(c) plan · 2G fully participant-directed · 3D IRS pre-approved plan · 3F · Form 5500, line 8a; TYPE_PENSION_BNFT_CODE pos 81; filing 20250723095416NAL0001783747002, received 2025-07-23
Full record, Syros Pharmaceuticals, Inc. 401(k) Plan
| Field | Value | Source |
|---|---|---|
| Plan sponsor | SYROS PHARMACEUTICALS, INC. | Form 5500, Part II line 2a; SPONSOR_DFE_NAME pos 19; filing 20250723095416NAL0001783747002, received 2025-07-23 |
| Plan name | SYROS PHARMACEUTICALS, INC. 401(K) PLAN | Form 5500, line 1a; PLAN_NAME pos 16; filing 20250723095416NAL0001783747002, received 2025-07-23 |
| Sponsor EIN / plan number | 45-3772460 / 001 | Form 5500, line 2b; SPONS_DFE_EIN pos 44; filing 20250723095416NAL0001783747002, received 2025-07-23 |
| Plan type | single-employer | Form 5500, Part I line A; TYPE_PLAN_ENTITY_CD pos 4; filing 20250723095416NAL0001783747002, received 2025-07-23 |
| Sponsor location | MESA, AZ | Form 5500, line 2a; SPONS_DFE_MAIL_US_STATE pos 25; filing 20250723095416NAL0001783747002, received 2025-07-23 |
| Industry (business code) | 325410, Manufacturing | Form 5500, line 2d; BUSINESS_CODE pos 46; filing 20250723095416NAL0001783747002, received 2025-07-23 |
| Plan year | 2024-01-01 to 2024-12-31 | Form 5500, Part I plan year; FORM_PLAN_YEAR_BEGIN_DATE pos 2; filing 20250723095416NAL0001783747002, received 2025-07-23 |
| Filing received | 2025-07-23 | Form 5500, EFAST2 receipt date; DATE_RECEIVED pos 102; filing 20250723095416NAL0001783747002, received 2025-07-23 |
| Final filing | no | Form 5500, Part I line B; FINAL_FILING_IND pos 8; filing 20250723095416NAL0001783747002, received 2025-07-23 |
| Amended filing | no | Form 5500, Part I line B; AMENDED_IND pos 7; filing 20250723095416NAL0001783747002, received 2025-07-23 |
| Participants, beginning of year | 181 | Form 5500, line 5; TOT_PARTCP_BOY_CNT pos 71; filing 20250723095416NAL0001783747002, received 2025-07-23 |
| Active participants | 4 | Form 5500, line 6a(2); TOT_ACTIVE_PARTCP_CNT pos 72; filing 20250723095416NAL0001783747002, received 2025-07-23 |
| Participants, end of year | 61 | Form 5500, line 6f; TOT_ACT_RTD_SEP_BENEF_CNT pos 77; filing 20250723095416NAL0001783747002, received 2025-07-23 |
| Participants with an account balance | 61 | Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20250723095416NAL0001783747002, received 2025-07-23 |
| Total assets, beginning of year | $16,166,576 | Schedule H, Part I line 1f col (a); TOT_ASSETS_BOY_AMT pos 30; filing 20250723095416NAL0001783747002, received 2025-07-23 |
| Total assets, end of year | $6,138,560 | Schedule H, Part I line 1f col (b); TOT_ASSETS_EOY_AMT pos 61; filing 20250723095416NAL0001783747002, received 2025-07-23 |
| Net assets, end of year | $6,138,560 | Schedule H, line 1l col (b); NET_ASSETS_EOY_AMT pos 67; filing 20250723095416NAL0001783747002, received 2025-07-23 |
| Total income | $5,400,465 | Schedule H, Part II line 2d; TOT_INCOME_AMT pos 97; filing 20250723095416NAL0001783747002, received 2025-07-23 |
| Net income | $-10,028,016 | Schedule H, line 2k; NET_INCOME_AMT pos 111; filing 20250723095416NAL0001783747002, received 2025-07-23 |
| Employer contributions | $605,771 | Schedule H, Part II line 2a(1)(A); EMPLR_CONTRIB_INCOME_AMT pos 68; filing 20250723095416NAL0001783747002, received 2025-07-23 |
| Participant contributions | $1,503,261 | Schedule H, line 2a(1)(B); PARTICIPANT_CONTRIB_AMT pos 69; filing 20250723095416NAL0001783747002, received 2025-07-23 |
| Other contributions (incl. rollovers) | $444,447 | Schedule H, line 2a(1)(C); OTH_CONTRIB_RCVD_AMT pos 70; filing 20250723095416NAL0001783747002, received 2025-07-23 |
| Total contributions | $2,553,479 | Schedule H, line 2a(3); TOT_CONTRIB_AMT pos 72; filing 20250723095416NAL0001783747002, received 2025-07-23 |
| Benefit payments | $15,376,498 | Schedule H, line 2e(4); TOT_DISTRIB_BNFT_AMT pos 101; filing 20250723095416NAL0001783747002, received 2025-07-23 |
| Total expenses (incl. benefit payments) | $15,428,481 | Schedule H, line 2j; TOT_EXPENSES_AMT pos 110; filing 20250723095416NAL0001783747002, received 2025-07-23 |
| Total administrative expenses | $51,983 | Schedule H, line 2i(12) total administrative expenses; TOT_ADMIN_EXPENSES_AMT pos 109; filing 20250723095416NAL0001783747002, received 2025-07-23 |
| Administrative expenses excluding investment management | $51,983 | derived, admin_expenses (2i(12)) minus invst_mgmt_fees (2i(5)), floored at 0; filing 20250723095416NAL0001783747002, received 2025-07-23 |
| Held in mutual funds | $6,108,600 | Schedule H, line 1c(13) col (b); INT_REG_INVST_CO_EOY_AMT pos 55; filing 20250723095416NAL0001783747002, received 2025-07-23 |
| Independent auditor | CARON & BLETZER, PLLC | Schedule H, Part III line 3a; ACCOUNTANT_FIRM_NAME pos 116; filing 20250723095416NAL0001783747002, received 2025-07-23 |
Position = column in the DOL layout for form year 2024. Filing 20250723095416NAL0001783747002, received 2025-07-23.
Service providers paid directly by the plan
| Provider | Relationship | Service codes | Direct compensation | Indirect |
|---|---|---|---|---|
| GLOBAL RETIREMENT PARTNERS LLC | INVESTMENT ADVISOR | 27 Investment advisory (plan) | $46,905 | no |
| FIDELITY INV INS OPS CO LLCrecordkeeper | RECORDKEEPER | 37 Participant loan processing; 64 Recordkeeping fees; 65 Account maintenance fees | $3,618 | yes |
| THE VANGUARD GROUP INC.recordkeeper | RECORDKEEPER | 64 Recordkeeping fees | $1,755 | yes |
| ASCENSUS LLCrecordkeeper | RECORDKEEPER | 64 Recordkeeping fees | $1 | yes |
Schedule C Part I line 2: name (a), service codes (b), relationship (c), direct compensation paid by the plan (d), indirect compensation received (e). Filing 20250723095416NAL0001783747002, received 2025-07-23.
What changed since the 2023 plan year
| Figure | 2023 | 2024 | Change |
|---|---|---|---|
| Total assets | $16,166,576 | $6,138,560 | -62.0% |
| Participants with a balance | 181 | 61 | -66.3% |
| Administrative expenses | $35,387 | $51,983 | 46.9% |
| Recordkeeping fees per participant | not reported | not reported | |
| Employer contributions | $935,254 | $605,771 | -35.2% |
Prior filing 20240726085553NAL0015185921002, received 2024-07-26; the plan years are contiguous.
Alerts, claims and corrections
Sponsor name as filed: SYROS PHARMACEUTICALS, INC.; SEC registrant: Syros Pharmaceuticals, Inc. (CIK 1556263, matched by EIN; display name from the Form 10-K cover).